Prophylaxis and treatment of influenza encephalitis in an experimental mouse model

Journal of Medical Virology

Volumn 67, Issue 3, 2002, Pages 406-417

  Shinjoh, Masayoshi ^a,b   Yoshikawa, Takashi ^c   Li, Yixing ^a   Shiraishi, Kyoko ^a   Ueki, Hideaki ^c   Nerome, Kuniaki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Amantadine; Antiserum; Influenza virus; Mouse; Vaccine

Indexed keywords

AMANTADINE; ANTISERUM; INACTIVATED VACCINE; INFLUENZA VACCINE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLIA CELL; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INTERMETHOD COMPARISON; MOUSE; NERVE CELL; NONHUMAN; PROPHYLAXIS; SURVIVAL; VIRUS ENCEPHALITIS; WEIGHT REDUCTION;

AMANTADINE; ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BRAIN; DISEASE MODELS, ANIMAL; DOGS; ENCEPHALITIS, VIRAL; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; LUNG; MICE; TREATMENT OUTCOME; VACCINES, INACTIVATED;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0036274005     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10088     Document Type: Article

References (48)

1. Equilibrium sedimentation of influenza virus in caesium chloride density gradients
2. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices (ACIP)
3. Flu and the American expeditionary force
4. Efficacy of combination therapy with AMN, thymosin, al and α/β interferon in mice infected with influenza A virus
5. Influenza A virus associated with acute encephalopathy
6. Animal influenza
7. Encephalopathy and pericarditis during an outbreak of influenza
8. Clinical effectiveness of influenza vaccination in Manitoba
9. Influenzal encephalopathy and postinfluenzal encephalitis
10. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis
11. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from human in Hong Kong
12. The role of interferon in influenza virus tissue tropism
13. Aerozol and intraperitoneal administration of ribavirin and ribavirin triacetate: Pharmacokinetics and protection of mice against intra-cerebral infection with influenza A/WSN virus
14. Maturation of influenza A virus hemagglutinin-estimates of the pH encountered during transport and its regulation by the M2 protein
15. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice
16. The molecular basis of the specific anti-influenza action of AMN
17. Emergence and transmission of influenza A viruses resistant to AMN and rimantadine
18. Neurologic disorders after Asian influenza
19. Detection of influenza virus RNA by reverse transcription-PCR and postinflammatory cytokines in influenza-virus-asssociated encephalopathy
20. Growth impairment resulting from expression of influenza virus M2 protein in Saccharomyces cerevisiae; identification of a novel inhibitor of influenza virus
21. Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: Evidence for genetic reassortment of the six internal genes
22. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
23. Nucleotide sequence of RNA segment 7 and the predicted amino acid sequence of M1 and M2 proteins of FPV/Weybridge (H7N7) and WSN (H1N1) influenza virus
24. Antiviral and adjuvant activity of immunomodulator adamantylamide dipeptide
25. Neurological disorders associated with Asian influenza
26. Orthomyxoviruses
27. Neurovirulence of influenza virus in mice. II. Mechanism of virulence as studied in a neuroblastoma cell line
28. The effectiveness of vaccination against influenza in healthy, working adults
29. In vivo selection of an influenza A2 strain resistant to AMN
30. Human infection with influenza H9N2
31. Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab') fragments
32. 1918 Influenza, encephalitis lethargica, parkinsonism
33. Pathogenesis of neurovirulent influenza A virus infection in mice-route of entry of virus into brain determines infection of different populations of cells
34. Influenza A virus associated neurological disorders in Jamaica
35. The specific inhibition of influenza A virus maturation by AMN; An electron microscopic examination
36. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4- dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)
37. Influenza type A-associated encephalopathy with bilateral thalamic necrosis in Japan
38. Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve
39. AMN therapy for influenza type A-associated encephalopathy
40. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B
41. Neurovirulence of influenza virus in mice. I. Neurovirulence of reconbinants between virulent and avirulent virus strains
42. Specific structural alteration of the influenza haemagglutinin by AMN
43. Excess mortality from influenza epidemics in Japan, 1980-1994
44. The substantia nigra is a major target for neurovirulent influenza A virus
45. Isolation of influenza virus "A/Hong Kong/1/68 (H3N2)" from liquor cerebrospinalis of patients with CNS involvement
46. Antivirals for the chemoprophylaxis and treatment of influenza
47. AMN and ribavirin aerosol treatment of influenza A and B infection in mice
48. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus